Regen Biopharma (PK) Stock Quote RGBPD - Stock Price, News, Charts, Message Board, Trades

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
USOTC
Regen Biopharma Inc (PK) (RGBPD) Quote

Regen Biopharma Inc (PK) (RGBPD)

2.015

0.00

(0.00%)

Closed September 12 4:00PM

Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Current Price

2.015

Bid

0.00

Ask

0.00

Volume

-

0.00 Day's Range 0.00

1.25 52 Week Range 3.00

Market Cap

Previous Close

2.015

Open

-

Last Trade

Last Trade Time

Financial Volume

-

VWAP

-

Average Volume (3m)

-

Shares Outstanding

3,381,000

Dividend Yield

-

PE Ratio

5.87

Earnings Per Share (EPS)

0.34

Revenue

237k

Net Profit

1.16M

Regen BioPharma Inc. is a publicly traded biotechnology company (OTCQB: RGBP) and (OTCQB: RGBPP). The Company is focused on the immunology and immunotherapy space. The Company is focused on rapidly advancing novel technologies through pre-clinical and Phase I/ II clinical trials. Currently, the Comp... Regen BioPharma Inc. is a publicly traded biotechnology company (OTCQB: RGBP) and (OTCQB: RGBPP). The Company is focused on the immunology and immunotherapy space. The Company is focused on rapidly advancing novel technologies through pre-clinical and Phase I/ II clinical trials. Currently, the Company is focused on small molecule therapies for treating cancer and autoimmune disorders. Additional information on Regen BioPharma is available at http://www.regenbiopharmainc.com. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.regenbiopharmainc.com

Headquarters

Reno, Nevada, USA

Founded

-

Regen Biopharma Inc (PK) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker RGBPD. The last closing price for Regen Biopharma (PK) was $2.02. Over the last year, Regen Biopharma (PK) shares have traded in a share price range of $ 1.25 to $ 3.00.

Regen Biopharma (PK) currently has 3,381,000 shares outstanding. The market capitalization of Regen Biopharma (PK) is $6.81 million. Regen Biopharma (PK) has a price to earnings ratio (PE ratio) of 5.87.

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 8-K - Current report

Form 424B3 - Prospectus [Rule 424(b)(3)]

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	-0.085	-4.04761904762	2.1	3	1.25	11278	2.00278478	CS
156	-0.085	-4.04761904762	2.1	3	1.25	11278	2.00278478	CS
260	0	0	0	0	0	0	0	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
ZLSSFZalatoris II Acquisition Corporation (CE)	$ 10.81 (982,627.27%)	6.39k
CSCHFChina Renaissance Holdings Ltd (PK)	$ 0.21 (11,566.67%)	3.67k
COHGCheetah Oil and Gas Ltd New (CE)	$ 0.0001 (9,900.00%)	45.77k
NTRRNeutra Corporation (CE)	$ 0.0001 (9,900.00%)	3.85M
HDIIHypertension Diagnositc Inc (CE)	$ 0.0001 (9,900.00%)	23k
MICRDMicron Solutions Inc (CE)	$ 0.000001 (-100.00%)	2.5k
ZHCLFZenith Capital Corporation (CE)	$ 0.000001 (-100.00%)	32.05k
BTAEFBeta Energy Corporation (CE)	$ 0.000001 (-99.95%)	521
BLSTFBlackstone Minerals Ltd (PK)	$ 0.0001 (-99.67%)	100
CCTLCoin Citadel (PK)	$ 0.000001 (-99.00%)	26.06k
RDARRaadr Inc (PK)	$ 0.0003 (200.00%)	425.41M
EARIEntertainment Arts Research Inc (PK)	$ 0.0003 (-25.00%)	337.57M
WNBDWinning Brands Corporation (PK)	$ 0.0001 (0.00%)	248.67M
SNWRSanwire Corporation (PK)	$ 0.0006 (0.00%)	131.39M
HMBLHUMBL Inc (PK)	$ 0.0002 (0.00%)	126.86M

axelvento

axelvento 2 minutes ago

Cancer vaccine breakthrough as tests show positive results on patients with tumours
The jab, known as mRNA-4359, is developed by Moderna

Researchers found tumours did not grow and no new tumours appeared in eight of the 16 patients who were evaluated

Scientists u

King Bolaba

King Bolaba 3 minutes ago

https://vietnamnews.vn/politics-laws/1662928/viet-nam-ready-to-contribute-to-a-bright-future-for-all-people-top-leader.html

getmoreshares

getmoreshares 3 minutes ago

https://x.com/Rothmus/status/1834408602888507452

Acme Investments

Acme Investments 3 minutes ago

I haven't heard one person who knows how the otc works say retail can short!! Institutional possibly!!

RealDutch

RealDutch 4 minutes ago

Have you decided yet whether to delay surgery on the 14th?

iateclube

iateclube 4 minutes ago

When was the last time this traded 10 million shares?

janice shell

janice shell 5 minutes ago

That will be... Challenging.

Adrock

Adrock 5 minutes ago

pos_stock_hoarder

pos_stock_hoarder 6 minutes ago

Best wishes to her and I hope the liver regenerates for her.

timberwolf7

timberwolf7 6 minutes ago

fanni the FRAUD/LIAR/CORRUPT DA, case in trouble.
Looking for the commie supporters to start screeching how
'unfair' this is..

https://media.gab.com/cdn-cgi/image/width=568,quality=100,fit=scale-down/system/media_attachments/files/166/107/527/original/c33aa5569b6a1e3d.j

newmedman

newmedman 7 minutes ago

Yeah definitely. I mean, I keep my tub clean but it's made from PVC and its 32 years old. When I installed it, it was gloss white and now its almond colored, inside and out. I was willing to sacrifice quality for price back then. LOL actually I didn't have a choice, we were just starting out and ne

timberwolf7

timberwolf7 8 minutes ago

Did the commie network abc RIG the debate?? Looks like it
IF this is whistleblower is still alive.

https://media.gab.com/cdn-cgi/image/width=568,quality=100,fit=scale-down/system/media_attachments/files/166/104/703/original/f0c31e291e61e243.jpg

PepperJacked

PepperJacked 8 minutes ago

CatBirdSeat

CatBirdSeat 8 minutes ago

JPS TO GET CUT, ANOUNCEMENT CSHIP OVER, THEN COMMONS TO THE MOON!!!

gfp927z

gfp927z 9 minutes ago

Bigworld, Another bearish factor for stocks is the growing reality that regardless of who wins the election, things are going to suck. If Harris wins, we are stuck with the same disastrous crew of 'Team B' incompetents running domestic and foreign policy. If Trump wins, the media and most of t

getmoreshares

getmoreshares 10 minutes ago

stash some cash too!

georgejjl

georgejjl 11 minutes ago

September 2024 Presentation from Anavex Life Sciences

https://www.anavex.com/_files/ugd/79bcf7_e5426a3b0863470aacd26f27e5fc4ae3.pdf

Good luck and GOD bless,

Chartmaster

Chartmaster 12 minutes ago

Breaking News! Trump announces NO TAXES ON OVERTIME!!! BOOOM! This is HUGE!!! Trump is so smart! He figured out a way to pay people to vote for him!
No taxes on tips and Overtime means real money in peeps pockets! This will draw huge vote from the working class!
And no taxes on social

justhefax

justhefax 12 minutes ago

you are correct imho

The sale hopefully also bundled some debt, but that is hope.

If the LLC was generating no revs and potential limited then the $ likely comes from Covert.

I have communicated with Brandon White, who is listed as President and i had a p

hookrider

hookrider 13 minutes ago

dbergh: You are not even worth replying too!!!!

EternalPatience

EternalPatience 14 minutes ago

Troll alert (sarcastic and sneaky troll, cunning too)

janice shell

janice shell 14 minutes ago

Not at all. Rick Wilson isn't just "that guy". He a very well known publicist who used to work for Republican politicians. He's still a conservative, but he correctly believes Trumpty will destroy the country.

His work is extremely effective.

You, I'm afraid, just don

primewa

primewa 14 minutes ago

DJT very clearly so clever. Why give another chance for done nothing in the last 3.5 years for the third debate? Everyone don't forgot DJT already first debate with her boss sleepy J. Sept 10 is the second debate and 3.5 years comes out bunch of accusation and liars. Will see who will be last laug

Turbomunkey

Turbomunkey 15 minutes ago

I am wondering if after the approval things pick up a bit. Will insiders have to wait until the merger occurs to buy?

Regen Biopharma (PK)

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions